secwatch.observer — SEC 8-K summary
======================================

Issuer:     Bicara Therapeutics Inc. (BCAX)
CIK:        0002023658
Form:       8-K
Filed at:   2025-06-12T23:59:59+00:00
Accession:  0002023658-25-000082
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Bicara Therapeutics shareholders elect three Class I directors, ratify KPMG
---------------------------------------------------------------------------

- Elected Kiran Mazumdar-Shaw, Jake Simson, and Ryan Cohlhepp as Class I directors for three-year terms.
- Vote results: Mazumdar-Shaw 30.8M for, 14.4M withheld; Simson 37.6M for, 7.6M withheld; Cohlhepp 44.8M for, 0.4M withheld.
- Broker non-votes of approximately 2.6M shares on each director election.
- Ratification of KPMG as auditor for FY2025 passed with 47.7M for, 7.8K against, 3.3K abstain.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/2023658/000202365825000082/0002023658-25-000082-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/2023658/000202365825000082/bcax-20250609.htm
  HTML page:      https://secwatch.observer/filing/0002023658-25-000082

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer